Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Iteos Therapeutics, Inc. (ITOS)
since 2020 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Iteos Therapeutics, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1808865.
Total stock buying since 2020: $133,923,239.
Total stock sales since 2020: $226,100,036.
Total stock option exercises since 2020: $3,652,137.
Table 3. Detailed insider trading at Iteos Therapeutics, Inc. (ITOS)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2025-06-10 | Detheux Michel (Chief Executive Officer) | Sale | 52,283 | 10.02 | 523,875 |
2025-06-10 | Detheux Michel (Chief Executive Officer) | Option Ex | 164,310 | 4.30 | 706,533 |
2025-06-09 | Detheux Michel (Chief Executive Officer) | Sale | 52,282 | 10.03 | 524,388 |
2025-06-09 | Detheux Michel (Chief Executive Officer) | Option Ex | 52,282 | 4.30 | 224,812 |
2025-06-06 | Detheux Michel (Chief Executive Officer) | Sale | 52,282 | 10.21 | 533,799 |
2025-06-06 | Detheux Michel (Chief Executive Officer) | Option Ex | 52,282 | 4.30 | 224,812 |
2025-06-06 | Hallal David | Sale | 38,228 | 10.24 | 391,454 |
2025-06-06 | Hallal David | Option Ex | 38,228 | 4.30 | 164,380 |
2025-06-05 | Detheux Michel (Chief Executive Officer) | Sale | 52,282 | 10.15 | 530,662 |
2025-06-05 | Detheux Michel (Chief Executive Officer) | Option Ex | 52,282 | 4.30 | 224,812 |
2025-06-05 | Hallal David | Sale | 38,227 | 10.15 | 388,004 |
2025-06-05 | Hallal David | Option Ex | 38,227 | 4.30 | 164,376 |
2025-06-04 | Detheux Michel (Chief Executive Officer) | Sale | 52,283 | 10.10 | 528,058 |
2025-06-04 | Detheux Michel (Chief Executive Officer) | Option Ex | 52,283 | 4.30 | 224,816 |
2025-06-04 | Hallal David | Sale | 38,227 | 10.07 | 384,945 |
2025-06-04 | Hallal David | Option Ex | 38,227 | 4.30 | 164,376 |
2025-05-15 | Ecor1 Capital, Llc | Buy | 3,300,000 | 8.00 | 26,400,000 |
2025-05-14 | Ecor1 Capital, Llc | Buy | 1,658,978 | 7.41 | 12,286,391 |
2025-05-13 | Mpm Bioventures 2018 Gp Llc | Sale | 630,191 | 8.06 | 5,079,339 |
2025-05-13 | Van Hauwermeiren Timothy | Option Ex | 22,346 | 4.30 | 96,087 |
2025-05-13 | Ubs Oncology Impact Fund L.p. | Sale | 1,031,931 | 8.06 | 8,317,363 |
2025-05-13 | Foley Todd | Sale | 630,191 | 8.06 | 5,079,339 |
2024-11-19 | Gall Matthew (Chief Financial Officer) | Buy | 5,000 | 7.73 | 38,635 |
2023-10-12 | Gall Matthew (Chief Financial Officer) | Buy | 5,000 | 8.37 | 41,849 |
2023-08-23 | Davis Aaron I. | Sale | 350,000 | 15.56 | 5,447,050 |
2023-03-28 | Call Matthew (Chief Operating Officer) | Option Ex | 40,226 | 2.95 | 118,666 |
2022-06-09 | Hallal David (Director) | Sale | 1,171 | 19.51 | 22,846 |
2022-06-09 | Hallal David (Director) | Option Ex | 1,171 | 4.23 | 4,953 |
2022-06-08 | Hallal David (Director) | Sale | 28,444 | 20.21 | 574,938 |
2022-06-08 | Hallal David (Director) | Option Ex | 28,444 | 3.80 | 108,172 |
2022-05-11 | Davis Aaron I. (Director) | Sale | 338,000 | 17.89 | 6,046,820 |
2022-05-10 | Davis Aaron I. (Director) | Sale | 100,000 | 24.97 | 2,497,300 |
2022-05-09 | Davis Aaron I. (Director) | Sale | 225,000 | 23.19 | 5,217,075 |
2022-05-02 | Davis Aaron I. (Director) | Sale | 100,000 | 27.22 | 2,721,900 |
2022-04-29 | Davis Aaron I. (Director) | Sale | 125,000 | 27.61 | 3,451,875 |
2022-04-28 | Davis Aaron I. (Director) | Sale | 150,000 | 27.40 | 4,110,300 |
2022-04-18 | Detheux Michel (Chief Executive Officer) | Sale | 11,500 | 32.26 | 370,932 |
2022-04-18 | Detheux Michel (Chief Executive Officer) | Option Ex | 11,500 | 4.23 | 48,645 |
2022-03-23 | Davis Aaron I. (Director) | Buy | 20,000 | 32.85 | 656,979 |
2022-03-22 | Detheux Michel (Chief Executive Officer) | Sale | 18,437 | 34.82 | 641,976 |
2022-03-22 | Davis Aaron I. (Director) | Buy | 30,000 | 32.80 | 983,940 |
2022-03-17 | Lewis Joseph (10% Owner) | Sale | 575,201 | 35.25 | 20,275,835 |
2022-03-11 | Lager Joanne Jenkins (Chief Medical Officer) | Sale | 3,500 | 36.01 | 126,035 |
2022-03-11 | Lager Joanne Jenkins (Chief Medical Officer) | Option Ex | 3,500 | 4.30 | 15,050 |
2022-03-01 | Mcgrath Yvonne (Chief Scientific Officer) | Sale | 10,000 | 36.76 | 367,570 |
2022-03-01 | Mcgrath Yvonne (Chief Scientific Officer) | Option Ex | 10,000 | 4.24 | 42,400 |
2022-02-23 | Detheux Michel (Chief Executive Officer) | Sale | 14,500 | 34.81 | 504,745 |
2022-02-11 | Lager Joanne Jenkins (Chief Medical Officer) | Sale | 3,500 | 35.90 | 125,632 |
2022-02-11 | Lager Joanne Jenkins (Chief Medical Officer) | Option Ex | 3,500 | 4.30 | 15,050 |
2022-01-25 | Detheux Michel (Chief Executive Officer) | Sale | 14,500 | 35.83 | 519,535 |
2022-01-14 | Lager Joanne Jenkins (Chief Medical Officer) | Sale | 3,500 | 39.41 | 137,952 |
2022-01-14 | Lager Joanne Jenkins (Chief Medical Officer) | Option Ex | 3,500 | 4.30 | 15,050 |
2022-01-05 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 18,135 | 42.03 | 762,214 |
2022-01-05 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 18,135 | 42.03 | 762,214 |
2022-01-05 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 30,347 | 42.03 | 1,275,484 |
2022-01-04 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 128,550 | 44.26 | 5,689,623 |
2022-01-04 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 128,550 | 44.26 | 5,689,623 |
2022-01-04 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 215,122 | 44.26 | 9,521,299 |
2022-01-04 | Davis Aaron I. (Director) | Sale | 184,677 | 43.78 | 8,085,159 |
2022-01-03 | Biniszkiewicz Detlev (Director) | Sale | 3,500 | 51.90 | 181,650 |
2022-01-03 | Biniszkiewicz Detlev (Director) | Option Ex | 3,500 | 19.00 | 66,500 |
2022-01-03 | Lager Joanne Jenkins (Chief Medical Officer) | Sale | 7,000 | 51.90 | 363,300 |
2022-01-03 | Lager Joanne Jenkins (Chief Medical Officer) | Option Ex | 7,000 | 4.30 | 30,100 |
2022-01-03 | Davis Aaron I. (Director) | Sale | 515,323 | 49.22 | 25,361,621 |
2021-12-27 | Gall Matthew (Chief Financial Officer) | Sale | 5,000 | 46.45 | 232,250 |
2021-12-22 | Detheux Michel (Chief Executive Officer) | Sale | 16,163 | 44.80 | 724,183 |
2021-12-22 | Detheux Michel (Chief Executive Officer) | Option Ex | 1,663 | 4.30 | 7,150 |
2021-12-21 | Detheux Michel (Chief Executive Officer) | Sale | 19,226 | 44.60 | 857,575 |
2021-12-21 | Detheux Michel (Chief Executive Officer) | Option Ex | 19,226 | 4.30 | 82,671 |
2021-12-20 | Detheux Michel (Chief Executive Officer) | Sale | 9,111 | 43.94 | 400,337 |
2021-12-20 | Detheux Michel (Chief Executive Officer) | Option Ex | 9,111 | 4.30 | 39,177 |
2021-12-20 | Hallal David (Director) | Sale | 50,000 | 43.57 | 2,178,500 |
2021-12-20 | Hallal David (Director) | Option Ex | 50,000 | 3.62 | 181,250 |
2021-12-17 | Lager Joanne Jenkins (Chief Medical Officer) | Sale | 7,000 | 41.00 | 287,000 |
2021-12-17 | Lager Joanne Jenkins (Chief Medical Officer) | Option Ex | 7,000 | 4.30 | 30,100 |
2021-12-10 | Lager Joanne Jenkins (Chief Medical Officer) | Sale | 3,500 | 34.50 | 120,750 |
2021-12-10 | Lager Joanne Jenkins (Chief Medical Officer) | Option Ex | 3,500 | 4.30 | 15,050 |
2021-12-07 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 19,456 | 33.63 | 654,305 |
2021-12-07 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 19,456 | 33.63 | 654,305 |
2021-12-07 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 32,558 | 33.63 | 1,094,925 |
2021-12-06 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 10,208 | 33.76 | 344,622 |
2021-12-06 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 10,208 | 33.76 | 344,622 |
2021-12-06 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 17,083 | 33.76 | 576,722 |
2021-12-03 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 20,167 | 35.46 | 715,121 |
2021-12-03 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 20,167 | 35.46 | 715,121 |
2021-12-03 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 33,749 | 35.46 | 1,196,739 |
2021-12-02 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 37,187 | 34.28 | 1,274,956 |
2021-12-02 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 37,187 | 34.28 | 1,274,956 |
2021-12-02 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 62,230 | 34.28 | 2,133,555 |
2021-12-01 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 12,395 | 34.59 | 428,743 |
2021-12-01 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 12,395 | 34.59 | 428,743 |
2021-12-01 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 20,742 | 34.59 | 717,465 |
2021-11-30 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 33,937 | 34.91 | 1,184,570 |
2021-11-30 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 33,937 | 34.91 | 1,184,570 |
2021-11-30 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 56,801 | 34.91 | 1,982,638 |
2021-11-29 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 10,371 | 34.91 | 362,103 |
2021-11-29 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 10,371 | 34.91 | 362,103 |
2021-11-29 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 17,356 | 34.91 | 605,984 |
2021-11-26 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 12,674 | 35.76 | 453,222 |
2021-11-26 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 12,674 | 35.76 | 453,222 |
2021-11-26 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 21,210 | 35.76 | 758,469 |
2021-11-24 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 36,337 | 36.09 | 1,311,402 |
2021-11-24 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 36,337 | 36.09 | 1,311,402 |
2021-11-24 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 60,808 | 36.09 | 2,194,560 |
2021-11-23 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 20,004 | 36.35 | 727,245 |
2021-11-23 | Detheux Michel (Chief Executive Officer) | Sale | 14,500 | 36.08 | 523,160 |
2021-11-23 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 20,004 | 36.35 | 727,245 |
2021-11-23 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 33,476 | 36.35 | 1,217,019 |
2021-11-22 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 21,114 | 37.48 | 791,458 |
2021-11-22 | Detheux Michel (Chief Executive Officer) | Option Ex | 16,263 | 12.45 | 202,474 |
2021-11-22 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 21,114 | 37.48 | 791,458 |
2021-11-22 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 35,333 | 37.48 | 1,324,457 |
2021-11-18 | Lager Joanne Jenkins (Chief Medical Officer) | Sale | 28,000 | 34.50 | 966,000 |
2021-11-18 | Lager Joanne Jenkins (Chief Medical Officer) | Option Ex | 28,000 | 4.30 | 120,400 |
2021-11-03 | Detheux Michel (Chief Executive Officer) | Sale | 6,085 | 28.89 | 175,777 |
2021-11-02 | Detheux Michel (Chief Executive Officer) | Sale | 14,391 | 28.41 | 408,920 |
2021-11-01 | Detheux Michel (Chief Executive Officer) | Sale | 81 | 28.00 | 2,268 |
2021-10-21 | Detheux Michel (Chief Executive Officer) | Sale | 196 | 28.00 | 5,488 |
2021-10-19 | Detheux Michel (Chief Executive Officer) | Sale | 201 | 28.00 | 5,628 |
2021-10-18 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 6,167 | 27.14 | 167,372 |
2021-10-18 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 6,167 | 27.14 | 167,372 |
2021-10-18 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 10,320 | 27.14 | 280,084 |
2021-10-15 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 10,932 | 27.77 | 303,581 |
2021-10-15 | Detheux Michel (Chief Executive Officer) | Sale | 1,635 | 28.01 | 45,796 |
2021-10-15 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 10,932 | 27.77 | 303,581 |
2021-10-15 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 18,295 | 27.77 | 508,052 |
2021-10-14 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 27,320 | 27.30 | 745,836 |
2021-10-14 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 27,320 | 27.30 | 745,836 |
2021-10-14 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 45,719 | 27.30 | 1,248,128 |
2021-10-13 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 20,929 | 27.13 | 567,803 |
2021-10-13 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 20,929 | 27.13 | 567,803 |
2021-10-13 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 35,023 | 27.13 | 950,173 |
2021-10-12 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 8,521 | 27.09 | 230,833 |
2021-10-12 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 8,521 | 27.09 | 230,833 |
2021-10-12 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 14,260 | 27.09 | 386,303 |
2021-10-11 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 48,812 | 27.24 | 1,329,638 |
2021-10-11 | Gall Matthew (Chief Financial Officer) | Option Ex | 14,429 | 6.16 | 88,882 |
2021-10-11 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 48,812 | 27.24 | 1,329,638 |
2021-10-11 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 81,684 | 27.24 | 2,225,072 |
2021-10-08 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 2,032 | 27.01 | 54,884 |
2021-10-08 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 2,032 | 27.01 | 54,884 |
2021-10-08 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 3,400 | 27.01 | 91,834 |
2021-10-07 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 1,149 | 27.00 | 31,023 |
2021-10-07 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 1,149 | 27.00 | 31,023 |
2021-10-07 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 1,922 | 27.00 | 51,894 |
2021-10-04 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 20,711 | 27.06 | 560,439 |
2021-10-04 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 20,711 | 27.06 | 560,439 |
2021-10-04 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 34,659 | 27.06 | 937,872 |
2021-10-01 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 6,855 | 27.00 | 185,085 |
2021-10-01 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 6,855 | 27.00 | 185,085 |
2021-10-01 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 11,471 | 27.00 | 309,717 |
2021-09-30 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 2,292 | 27.00 | 61,884 |
2021-09-30 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 2,292 | 27.00 | 61,884 |
2021-09-30 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 3,836 | 27.00 | 103,572 |
2021-09-28 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 19,214 | 27.00 | 518,778 |
2021-09-28 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 19,214 | 27.00 | 518,778 |
2021-09-28 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 32,154 | 27.00 | 868,158 |
2021-09-27 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 11,625 | 27.09 | 314,921 |
2021-09-27 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 11,625 | 27.09 | 314,921 |
2021-09-27 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 19,455 | 27.09 | 527,035 |
2021-09-24 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 4,913 | 27.81 | 136,630 |
2021-09-24 | Detheux Michel (Chief Executive Officer) | Sale | 1,089 | 28.02 | 30,511 |
2021-09-24 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 4,913 | 27.81 | 136,630 |
2021-09-24 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 8,221 | 27.81 | 228,626 |
2021-09-23 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 36,930 | 28.17 | 1,040,318 |
2021-09-23 | Detheux Michel (Chief Executive Officer) | Sale | 5,322 | 28.16 | 149,862 |
2021-09-23 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 36,930 | 28.17 | 1,040,318 |
2021-09-23 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 61,800 | 28.17 | 1,740,906 |
2021-09-22 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 14,294 | 27.54 | 393,656 |
2021-09-22 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 14,294 | 27.54 | 393,656 |
2021-09-22 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 23,921 | 27.54 | 658,784 |
2021-09-21 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 19,635 | 27.47 | 539,373 |
2021-09-21 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 19,635 | 27.47 | 539,373 |
2021-09-21 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 32,858 | 27.47 | 902,609 |
2021-09-20 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 24,303 | 27.43 | 666,752 |
2021-09-20 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 24,303 | 27.43 | 666,752 |
2021-09-20 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 40,673 | 27.43 | 1,115,863 |
2021-09-17 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 45,698 | 28.82 | 1,317,016 |
2021-09-17 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 45,698 | 28.82 | 1,317,016 |
2021-09-17 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 76,473 | 28.82 | 2,203,951 |
2021-09-16 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 21,253 | 28.47 | 605,072 |
2021-09-16 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 21,253 | 28.47 | 605,072 |
2021-09-16 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 35,565 | 28.47 | 1,012,535 |
2021-09-15 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 24,104 | 27.97 | 674,188 |
2021-09-15 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 24,104 | 27.97 | 674,188 |
2021-09-15 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 40,336 | 27.97 | 1,128,197 |
2021-09-14 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 21,561 | 27.75 | 598,209 |
2021-09-14 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 21,561 | 27.75 | 598,209 |
2021-09-14 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 36,081 | 27.75 | 1,001,067 |
2021-09-13 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 21,384 | 27.64 | 591,053 |
2021-09-13 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 21,384 | 27.64 | 591,053 |
2021-09-13 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 35,785 | 27.64 | 989,097 |
2021-09-10 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 13,531 | 28.30 | 382,859 |
2021-09-10 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 13,531 | 28.30 | 382,859 |
2021-09-10 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 22,643 | 28.30 | 640,683 |
2021-09-09 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 22,725 | 28.97 | 658,343 |
2021-09-09 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 22,725 | 28.97 | 658,343 |
2021-09-09 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 38,028 | 28.97 | 1,101,671 |
2021-09-08 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 12,092 | 28.86 | 348,914 |
2021-09-08 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 12,092 | 28.86 | 348,914 |
2021-09-08 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 20,236 | 28.86 | 583,909 |
2021-09-07 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 30,474 | 29.18 | 889,231 |
2021-09-07 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 30,474 | 29.18 | 889,231 |
2021-09-07 | Oncology Impact Fund (cayman) Management L.p. (10% Owner) | Sale | 50,996 | 29.18 | 1,488,063 |
2021-09-02 | Detheux Michel (Chief Executive Officer) | Sale | 11,568 | 29.20 | 337,831 |
2021-09-01 | Detheux Michel (Chief Executive Officer) | Sale | 8,684 | 28.30 | 245,722 |
2021-08-31 | Detheux Michel (Chief Executive Officer) | Sale | 4,093 | 28.12 | 115,095 |
2021-08-30 | Detheux Michel (Chief Executive Officer) | Sale | 2,322 | 28.01 | 65,039 |
2021-08-27 | Detheux Michel (Chief Executive Officer) | Sale | 8,248 | 28.17 | 232,346 |
2021-08-25 | Detheux Michel (Chief Executive Officer) | Sale | 861 | 28.00 | 24,108 |
2021-08-24 | Detheux Michel (Chief Executive Officer) | Sale | 225 | 28.26 | 6,358 |
2021-08-23 | Detheux Michel (Chief Executive Officer) | Sale | 7,499 | 28.06 | 210,421 |
2021-07-30 | Call Matthew (Chief Operating Officer) | Option Ex | 53,672 | 2.95 | 158,332 |
2021-06-16 | Gall Matthew (Chief Financial Officer) | Buy | 5,000 | 26.09 | 130,445 |
2021-06-08 | Mcgrath Yvonne (VP, Research and Development) | Sale | 7,927 | 20.00 | 158,540 |
2021-06-08 | Mcgrath Yvonne (VP, Research and Development) | Option Ex | 7,927 | 4.23 | 33,531 |
2021-06-02 | Mcgrath Yvonne (VP, Research and Development) | Sale | 323 | 20.00 | 6,460 |
2021-06-02 | Mcgrath Yvonne (VP, Research and Development) | Option Ex | 323 | 4.23 | 1,366 |
2021-06-01 | Mcgrath Yvonne (VP, Research and Development) | Sale | 7,604 | 20.18 | 153,441 |
2021-06-01 | Mcgrath Yvonne (VP, Research and Development) | Option Ex | 7,604 | 4.23 | 32,164 |
2021-04-09 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 119 | 29.99 | 3,568 |
2021-04-09 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 119 | 29.99 | 3,568 |
2021-04-08 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 19,304 | 30.76 | 593,791 |
2021-04-08 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 19,304 | 30.76 | 593,791 |
2021-04-08 | Mpm Oncology Impact Management Gp Llc (10% Owner) | Sale | 32,304 | 30.76 | 993,671 |
2021-04-07 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Sale | 5,783 | 32.92 | 190,359 |
2021-04-07 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Sale | 5,783 | 32.92 | 190,359 |
2021-04-07 | Mpm Oncology Impact Management Gp Llc (10% Owner) | Sale | 9,678 | 32.92 | 318,570 |
2020-07-28 | Mpm Bioventures 2018 Gp Llc (10% Owner) | Buy | 160,000 | 19.00 | 3,040,000 |
2020-07-28 | Mpm Asset Management Investors Bv2018 Llc (10% Owner) | Buy | 160,000 | 19.00 | 3,040,000 |
2020-07-28 | Oncology Impact Fund (cayman) Management L.p. (Other) | Buy | 320,000 | 19.00 | 6,080,000 |
2020-07-28 | Shah Rajeev M. | Buy | 1,425,000 | 19.00 | 27,075,000 |
2020-07-28 | Mva Investors, Llc (10% Owner) | Buy | 1,425,000 | 19.00 | 27,075,000 |
2020-07-28 | Davis Aaron I. (Director) | Buy | 1,425,000 | 19.00 | 27,075,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ITOS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Iteos Therapeutics, Inc. (symbol ITOS,
CIK number 1808865) see
the Securities and Exchange Commission (SEC) website.